We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Correspondence |

Pain as the Fifth Vital Sign

Paul Rousseau, MD
Arch Surg. 2008;143(1):98. doi:10.1001/archsurg.2007.23.
Text Size: A A A
Published online


I read with interest the commentaries on pain as the fifth vital sign by Drs Kozol, Voytovich, and Livingston in the May issue of the Archives.1,2 Although their subjective comments regarding the adverse consequences of pain as a fifth vital sign are bolstered by referenced studies, they fail to address one of the primary reasons for unfavorable outcomes in the arena of pain management: a lack of education among physicians regarding pain management principles and analgesic pharmacology. Dr Livingston makes the point best when he describes the litigation of an 85-year-old elderly gentleman with pulmonary compromise who suffered a respiratory arrest in the emergency department after receiving morphine (I wonder what dose of morphine he received and whether he was opioid naive) but was then admitted and variously prescribed a fentanyl citrate patch, meperidine, and acetaminophen/hydrocodone. Although the chronological use of these medications is not indicated, fentanyl patches are best used for nonacute pain (and it appears this gentleman was in acute pain), and meperidine is essentially contraindicated in someone 85 years of age, in part secondary to potential accumulation of the active metabolite normeperidine, which can precipitate anxiety, tremors, and seizures. The patient was then discharged, and because of apparent poor pain control, he visited another physician to seek pain relief and subsequently died of an alleged adverse response to morphine. The circumstances of this case are sad, and the outcome regrettable.

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview





Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
PubMed Articles

Care at the Close of Life: Evidence and Experience
Pain and Opioid-Induced Neurotoxicity Contributing to Fatigue

Care at the Close of Life: Evidence and Experience
Treatment of Pain and Opioid-Induced Neurotoxicity